Literature DB >> 8606778

Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2.

P Colas1, B Cohen, T Jessen, I Grishina, J McCoy, R Brent.   

Abstract

A network of interacting proteins controls the activity of cyclin-dependent kinase 2 (Cdk2) (refs 1,2) and governs the entry of higher eukaryotic cells into S phase. Analysis of this and other genetic regulatory networks would be facilitated by intracellular reagents that recognize specific targets and inhibit specific network connections. We report here the expression of a combinatorial library of constrained 20-residue peptides displayed by the active-site loop of Escherichia coli thioredoxin, and the use of a two-hybrid system to select those that bind human Cdk2. These peptide aptamers were designed to mimic the recognition function of the complementarity-determining regions of immunoglobulins. The aptamers recognized different epitopes on the Cdk2 surface with equilibrium dissociation constant in the nanomolar range; those tested inhibited Cdk2 activity. Our results show that peptide aptamers bear some analogies with monoclonal antibodies, with the advantages that they are isolated together with their coding genes, that their small size should allow their structures to be solved, and that they are designated to function inside cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606778     DOI: 10.1038/380548a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Establishment of a chemical synthetic lethality screen in cultured human cells.

Authors:  A Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

Review 3.  Chemical genetics: ligand-based discovery of gene function.

Authors:  B R Stockwell
Journal:  Nat Rev Genet       Date:  2000-11       Impact factor: 53.242

4.  RNA aptamers as effective protein antagonists in a multicellular organism.

Authors:  H Shi; B E Hoffman; J T Lis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections.

Authors:  C R Geyer; A Colman-Lerner; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Isolation of peptide aptamers that inhibit intracellular processes.

Authors:  J H Blum; S L Dove; A Hochschild; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

7.  Cytoplasmic RNA modulators of an inside-out signal-transduction cascade.

Authors:  M Blind; W Kolanus; M Famulok
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Targeted modification and transportation of cellular proteins.

Authors:  P Colas; B Cohen; P Ko Ferrigno; P A Silver; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

9.  Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments.

Authors:  Tom Wehrman; Benjamin Kleaveland; Jeng-Horng Her; Robert F Balint; Helen M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

10.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.